Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population

Stroke

Volumn 37, Issue 7, 2006, Pages 1715-1719

  Hays, Allison G ^c   Sacco, Ralph L ^b   Rundek, Tanja ^a   Sciacca, Robert R ^a   Jin, Zhezhen ^a   Liu, Rui ^a   Homma, Shunichi ^a   Di Tullio, Marco R ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Cerebrovascular disorders; Echocardiography; Left ventricular function

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNOLOGY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE; AFRICAN AMERICAN; BRAIN EMBOLISM; BRAIN ISCHEMIA; CAUCASIAN; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ECHOGRAPHY; EPIDEMIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HISPANIC; HYPERTENSION; INCIDENCE; MIDDLE AGED; RISK; SMOKING; STATISTICS; SYSTOLE; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COHORT STUDIES; DIABETES MELLITUS; ECHOCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; HYPERTENSION; INCIDENCE; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; NEW YORK CITY; ODDS RATIO; RISK FACTORS; SAMPLING STUDIES; SMOKING; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33745939214     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000227121.34717.40     Document Type: Article

References (24)

1. American Heart Association. Heart Disease and Stroke Statistics-2004 Update. Dallas, Tex. Am Heart Association; 2003.
2. Pullicino PM, Halperin J, Thompson J. Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology. 2000;54:288-298.
3. Hobbie RK, McKee PA. Survival of patients with congestive heart failure. N Eng J Med. 1972;286:606-607.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation, a major contributor to stroke in the elderly; the Framingham study. Arch Int Med. 1987;147:1561-1564.
5. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE. Prevalence of heart failure and left ventricular dysfunction in the general population: the Rotterdam Study. Eur Heart J. 1999;20:447-455.
6. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, Dargia HJ. Symptomatic and asymptomatic left-ventricular dysfunction in an urban population. Lancet. 1997;350:829-833.
7. Brockell. Prevalence of left ventricular dysfunction in the general population. J Am Coll Cardiol. 1996;27:25-30.
8. Morgan S, Smith H, Simpson I, Liddiard GS, Raphael H, Pickering RM, Mant D. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey. BMJ. 1999;318:368-372.
9. Kober L, Torp-Pedersen C, Otteses M, Burchardt H, Korup E, Lyngborg K. Influence of age on the prognostic importance of left ventricular dysfunction and congestive heart failure on long-term survival after acute MI. TRACE study group. Am J Cardiol. 1996;78:158-162.
10. Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker JC, Gottlieb SS, Lamas GA, Moye LA, Goldhaber SZ, Pfeffer MA. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251-257.
11. Sacco RL, Ellenberg JA, Mohr JP, Tatemichi TK, Wolf PA, Hier DB, Price TR. Infarction of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989;25:382-390.
12. Weyman AE. Principles and practice of echocardiography. Lea & Febiger Publ. 1994;606.
13. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
14. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol. 1997;29:1074-1080.
15. Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331-336.
16. Kelly R, Stained A, MacWalter R, Stonebridge P, Tunstall-Pedoe H, Struthers AD. The prevalence of treatable systolic dysfunction in patients who present with noncardiac vascular episodes: a case-control study. J Am Coll Cardiol. 2002;39:219-224.
17. Wang TJ, Levy D, Benjamin EJ, Vasan RS. The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening. Ann Intern Med. 2003;138:907-916.
18. Davies M, Hobbs F, Davis R, Kenkre J, Roalfe AK, Hare R, Wosornu D, Lancashire RJ. Prevalence of left ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet. 2001;358:439-444.
19. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 2003;108:977-982.
20. Sharkey SW, Shear W, Hodges M, Herzog CA. Reversible myocardial contraction abnormalities in patients with an acute noncardiac illness. Chest. 1998;114:98-105.
21. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669-677.
22. Doughty RN, Whalley GA, Walsh HA, Gamble GD, Lopez-Sendon J, Sharpe N; CAPRICORN Echo Substudy Investigators. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation. 2004;109:201-206.
23. β-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1982;247:1707-1714.
24. Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801-807.